SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-24-001202
Filing Date
2024-05-20
Accepted
2024-05-20 16:24:40
Documents
71
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q axim_10q.htm   iXBRL 10-Q 1226827
2 CERTIFICATION axim_ex311.htm EX-31.1 11144
3 CERTIFICATION axim_ex312.htm EX-31.2 11195
4 CERTIFICATION axim_ex321.htm EX-32.1 3507
5 CERTIFICATION axim_ex322.htm EX-32.2 3237
11 axim_10qimg2.jpg GRAPHIC 4918
  Complete submission text file 0001096906-24-001202.txt   6106038

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA axim-20240331.xsd EX-101.SCH 65334
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE axim-20240331_lab.xml EX-101.LAB 376353
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axim-20240331_cal.xml EX-101.CAL 53823
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axim-20240331_pre.xml EX-101.PRE 321291
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axim-20240331_def.xml EX-101.DEF 212218
75 EXTRACTED XBRL INSTANCE DOCUMENT axim_10q_htm.xml XML 829927
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 24964943
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)